Upstream Bio (UPB) FCF Margin (2023 - 2025)
Historic FCF Margin for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 3265.59%.
- Upstream Bio's FCF Margin fell 9654300.0% to 3265.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 4376.74%, marking a year-over-year decrease of 18543100.0%. This contributed to the annual value of 2518.27% for FY2024, which is 9186900.0% down from last year.
- Per Upstream Bio's latest filing, its FCF Margin stood at 3265.59% for Q3 2025, which was down 9654300.0% from 4187.73% recorded in Q2 2025.
- In the past 5 years, Upstream Bio's FCF Margin ranged from a high of 1575.69% in Q2 2024 and a low of 7272.97% during Q1 2025
- Over the past 3 years, Upstream Bio's median FCF Margin value was 3247.56% (recorded in 2024), while the average stood at 3519.47%.
- Per our database at Business Quant, Upstream Bio's FCF Margin surged by 3504700bps in 2024 and then crashed by -45289100bps in 2025.
- Over the past 3 years, Upstream Bio's FCF Margin (Quarter) stood at 3580.0% in 2023, then rose by 10bps to 3229.53% in 2024, then decreased by -1bps to 3265.59% in 2025.
- Its FCF Margin was 3265.59% in Q3 2025, compared to 4187.73% in Q2 2025 and 7272.97% in Q1 2025.